Yves Sabbagh, PhD
About Yves Sabbagh, PhD
Yves Sabbagh, PhD, serves as the Chief Scientific Officer at Inozyme Pharma, bringing over 20 years of experience in rare genetic disorders and mineral metabolism. He has held significant roles at Sanofi Genzyme and Massachusetts General Hospital, contributing to research and leadership in the field.
Current Role at Inozyme Pharma
Yves Sabbagh serves as the Chief Scientific Officer at Inozyme Pharma since 2020. In this role, he leads the scientific strategy and oversees research initiatives aimed at developing novel therapeutic approaches for rare genetic disorders. His expertise in rare genetic disorders and mineral metabolism informs the company's research direction and project development.
Previous Experience at Sanofi Genzyme
Prior to his current position, Yves Sabbagh held several roles at Sanofi Genzyme. He served as R&D Director from 2017 to 2020, where he focused on research and development in rare renal and musculoskeletal diseases. He also worked as Senior Principal Scientist/Associate Director from 2015 to 2017, contributing to the advancement of scientific knowledge in these areas. Additionally, he briefly served as Head of Rare Renal and Musculoskeletal Diseases Research in 2020.
Educational Background
Yves Sabbagh has a robust educational background in the life sciences. He earned a Ph.D. in Biology from McGill University, where he studied from 1998 to 2002. Prior to this, he completed a Master of Science in Microbiology and Immunology at Université Laval from 1996 to 1998. He also holds a Bachelor of Science in Biochemistry from McGill University, which he obtained from 1993 to 1996.
Leadership and Collaboration
With over 14 years of experience in managing scientists and research associates, Yves Sabbagh demonstrates strong leadership skills. He has maintained a collaborative network with thought leaders and scientists in the fields of renal, bone, and mineral metabolism for over 18 years, fostering partnerships that enhance research and development efforts in these specialized areas.
Publications and Scientific Contributions
Yves Sabbagh has co-authored more than 30 peer-reviewed publications and book chapters, contributing significantly to the scientific community. His work focuses on the discovery and evaluation of novel therapeutic approaches for rare genetic disorders, reflecting his expertise in this critical area of research.